It belongs to a class of medications called GLP-1 receptor agonists
They would have an offending agent into the gut, and they'd notice that there'd be protection deeper down in the, in the gastric tract from that offending agent
Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist that is used to treat obesity, type 2 diabetes, and weight-related health conditions such as metabolic dysfunction-associated steatohepatitis (MASH)
Key Benefits: Accelerated Tissue Healing & Regeneration: Supports rapid healing of muscles, tendons, ligaments, skin, and bones Gastrointestinal Support: Originally isolated from gastric juice, BPC-157 plays a crucial role in maintaining Gut Integrity
Serious adverse effects are rare when taken as prescribed under medical supervision
Potential Side Effects Like any other treatment, it is important to understand the potential side effects and risks